stockrowSeer, Inc. (SEER) vs VAXART, INC. (VXRT)
- Seer, Inc. SEER 1.64 −3.53%
- VAXART, INC. VXRT 0.37 −7.50%
Seer, Inc. and VAXART, INC. are both Biotechnology companies. Seer, Inc. and VAXART, INC. are of similar size ($94.1M and $92.4M). Seer, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. grew revenue faster over the last twelve months: 22.3% against −12.7%. VAXART, INC. has the higher net margin (16.0% vs −478.1%) and the higher return on invested capital (2,542.3% vs −60.8%). Across the 18 metrics below, VAXART, INC. leads on 15 and Seer, Inc. on 3.
Valuation
Profitability
| Metric | SEER | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 47.70% | 100.00% | 65.16% |
| Operating margin | (498.19%) | 16.63% | 0.00% |
| Net margin | (478.05%) | 16.02% | 0.00% |
| Free cash flow margin | (309.34%) | 17.64% | 0.00% |
| Return on equity | (26.45%) | 62.42% | (50.12%) |
| Return on assets | (23.47%) | 16.26% | (45.60%) |
| Return on invested capital | (60.78%) | 2,542.26% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack